Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Blood Purif ; 29(4): 375-82, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20484898

RESUMO

Thrombocytopenia is a common complication in patients receiving continuous veno-venous hemofiltration (CVVH) in the intensive care unit. The hemofilter itself plays an important role in the genesis of thrombocytopenia. The present study was undertaken to test whether there were differences in platelet loss and activation during CVVH with a polysulfone (PS) hemofilter or a cellulose triacetate (CTA) dialyzer. 96 patients with thrombocytopenia and acute kidney injury requiring CVVH were randomly assigned to four groups receiving low-molecular-weight heparin (LMWH) PS (n = 24), LMWH CTA (n = 24), no anticoagulation PS (n = 24), and no anticoagulation CTA (n = 24), respectively. We found a significant decrease in platelet counts, but an increased platelet activation with the PS hemofilter in patients who received no anticoagulation. There was no significant decrease in platelet counts and activation in the CTA group. The cellulose membranes could be an effective alternative to the standard synthetic membranes in patients at high risk for thrombocytopenia during CVVH.


Assuntos
Celulose/análogos & derivados , Hemofiltração/efeitos adversos , Trombocitopenia/etiologia , Adulto , Idoso , Celulose/efeitos adversos , Celulose/uso terapêutico , Feminino , Hemofiltração/instrumentação , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Ativação Plaquetária , Contagem de Plaquetas , Polímeros/efeitos adversos , Polímeros/uso terapêutico , Sulfonas/efeitos adversos , Sulfonas/uso terapêutico , Trombocitopenia/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA